Empty Capsules Market Analysis By Product (Gelatin, Non-Gelatin Capsules), By Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Anti-anemic Preparations, Anti-Inflammatory & Anti-rheumatic Drugs, Cardiac Therapy Drugs, Cough & Cold Preparations), By End-user(Pharmaceutical, Nutraceutical, Cosmetics Industries, Research laboratories) And Segment Forecasts To 2024
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 EMPTY CAPSULES INDUSTRY OUTLOOK
3.1 Market segmentation
3.2 Empty capsules market dynamics
3.3 Market driver analysis
3.4 Market restraint analysis
3.5 Key Opportunities Prioritized
3.6 Industry analysis - Porter’s
3.7 Empty capsules market PESTEL Analysis
CHAPTER 4 GLOBAL EMPTY CAPSULES PRODUCT OUTLOOK
4.1 Empty capsules market share by product, 2015 & 2024
4.2 Gelatin capsules
4.2.1 Gelatin capsules market estimates and forecasts, 2013 - 2024 (USD Billion)
4.3 Non gelatin capsules market
4.2.1 Non gelatin capsules market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 5 GLOBAL EMPTY CAPSULES MARKET THERAPEUTIC APPLICATION OUTLOOK
5.1 Empty capsules market share by therapeutic application, 2015 & 2024
5.2 Antibiotic and antibacterial drug
5.2.1 Antibiotic and antibacterial drug market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3 Vitamins and dietary supplements
5.3.1 Vitamins and dietary supplements marketestimates and forecasts, 2013 - 2024 (USD Billion)
5.4 Antacid and antiflatulent preparations
5.4.1 Antacid and antiflatulent preparations market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5 Antianemic preparations (Hematenic preparations)
5.5.1 Antianemic preparations (Hematenic preparations) market estimates and forecasts, 2013 - 2024 (USD Billion)
5.6 Anti-imflammatory and Antirheumatic drugs market
5.6.1 Anti-imflammatory and Antirheumatic drugs market estimates and forecasts, 2013 - 2024 (USD Billion)
5.7 Cardiac Therapy Drugs Market
5.7.1 Cardiac Therapy Drugs Market estimates and forecasts, 2013 - 2024 (USD Billion)
5.8 Cough and cold preparations market
5.8.1 Cough and cold preparations marketestimates and forecasts, 2013 - 2024 (USD Billion)
5.9 Other theraoeutic applications
5.9.1 Other therapeutic applications market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 6GLOBAL EMPTY CAPSULES MARKET, END USEROUTLOOK
6.1 Empty capsules market share by end user, 2015 & 2024
6.2 Pharmaceutical industry market
6.2.1 Pharmaceutical industry market estimates and forecasts, 2013 - 2024 (USD Billion)
6.3 Nutraceutical industry market
6.3.1 Nutraceutical industry marketestimates and forecasts, 2013 - 2024 (USD Billion)
6.4 Cosmeceutical industry market
6.4.1 Cosmeceutical industry market estimates and forecasts, 2013 - 2024 (USD Billion)
6.5 Research laboratories market
6.5.1 Research laboratories market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 7 GLOBAL EMPTY CAPSULES MARKET REGIONAL OUTLOOK
7.1 Empty capsules market share, by region, 2015 & 2024
7.2 North America
7.2.1 North America empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.2.1.1 U.S. market estimates and forecasts
7.2.1.2 Canada market estimates and forecasts
7.2.2 North America empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.2.2.1 U.S. market estimates and forecasts
7.2.2.2 Canadamarket estimates and forecasts
7.2.3 North America empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.2.3.1 U.S. market estimates and forecasts
7.2.3.2 Canada market estimates and forecasts
7.3 Europe
7.3.1 Europe empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.3.1.1 UK market estimates and forecasts
7.3.1.2 Germany market estimates and forecasts
7.3.2 Europe empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.3.2.1 UK market estimates and forecasts
7.3.2.2 Germany market estimates and forecasts
7.3.3 Europe empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.3.3.1 UK market estimates and forecasts
7.3.3.2 Germany market estimates and forecasts
7.4 Asia Pacific
7.4.1 Asia Pacific empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.4.1.1 Japan market estimates and forecasts
7.4.1.2 China market estimates and forecasts
7.4.2 Asia Pacific empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.4.2.1 Japan market estimates and forecasts
7.4.2.2 China market estimates and forecasts
7.4.3 Asia Pacific empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.4.3.1 Japan market estimates and forecasts
7.4.3.2 China market estimates and forecasts
7.5 Latin America
7.5.1 Latin America empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.5.1.1 Brazil market estimates and forecasts
7.5.1.2 Mexico market estimates and forecasts
7.5.2 Latin America empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.5.2.1 Brazil market estimates and forecasts
7.5.2.2 Mexicomarket estimates and forecasts
7.5.3 Latin America empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.5.3.1 Brazil market estimates and forecasts
7.5.3.2 Mexicomarket estimates and forecasts
7.6 MEA
7.6.1 MEA empty capsules market estimates and forecasts, by product, 2013 - 2024 (USD Billion)
7.6.1.1 South Africa market estimates and forecasts
7.6.2 MEA empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.6.2.1 South Africa market estimates and forecasts
7.6.3 MEA empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.6.3.1 South Africa market estimates and forecasts
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Capsugel.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 ACG Worldwide.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 JC biological technologies.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Capscanada Corporation
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Medicaps Ltd
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Qualicaps
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Patheon Ltd
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Roxlor LLC.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Sunil Healthcare Ltd
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Nectar Lifesciences Ltd
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 EMPTY CAPSULES INDUSTRY OUTLOOK
3.1 Market segmentation
3.2 Empty capsules market dynamics
3.3 Market driver analysis
3.4 Market restraint analysis
3.5 Key Opportunities Prioritized
3.6 Industry analysis - Porter’s
3.7 Empty capsules market PESTEL Analysis
CHAPTER 4 GLOBAL EMPTY CAPSULES PRODUCT OUTLOOK
4.1 Empty capsules market share by product, 2015 & 2024
4.2 Gelatin capsules
4.2.1 Gelatin capsules market estimates and forecasts, 2013 - 2024 (USD Billion)
4.3 Non gelatin capsules market
4.2.1 Non gelatin capsules market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 5 GLOBAL EMPTY CAPSULES MARKET THERAPEUTIC APPLICATION OUTLOOK
5.1 Empty capsules market share by therapeutic application, 2015 & 2024
5.2 Antibiotic and antibacterial drug
5.2.1 Antibiotic and antibacterial drug market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3 Vitamins and dietary supplements
5.3.1 Vitamins and dietary supplements marketestimates and forecasts, 2013 - 2024 (USD Billion)
5.4 Antacid and antiflatulent preparations
5.4.1 Antacid and antiflatulent preparations market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5 Antianemic preparations (Hematenic preparations)
5.5.1 Antianemic preparations (Hematenic preparations) market estimates and forecasts, 2013 - 2024 (USD Billion)
5.6 Anti-imflammatory and Antirheumatic drugs market
5.6.1 Anti-imflammatory and Antirheumatic drugs market estimates and forecasts, 2013 - 2024 (USD Billion)
5.7 Cardiac Therapy Drugs Market
5.7.1 Cardiac Therapy Drugs Market estimates and forecasts, 2013 - 2024 (USD Billion)
5.8 Cough and cold preparations market
5.8.1 Cough and cold preparations marketestimates and forecasts, 2013 - 2024 (USD Billion)
5.9 Other theraoeutic applications
5.9.1 Other therapeutic applications market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 6GLOBAL EMPTY CAPSULES MARKET, END USEROUTLOOK
6.1 Empty capsules market share by end user, 2015 & 2024
6.2 Pharmaceutical industry market
6.2.1 Pharmaceutical industry market estimates and forecasts, 2013 - 2024 (USD Billion)
6.3 Nutraceutical industry market
6.3.1 Nutraceutical industry marketestimates and forecasts, 2013 - 2024 (USD Billion)
6.4 Cosmeceutical industry market
6.4.1 Cosmeceutical industry market estimates and forecasts, 2013 - 2024 (USD Billion)
6.5 Research laboratories market
6.5.1 Research laboratories market estimates and forecasts, 2013 - 2024 (USD Billion)
CHAPTER 7 GLOBAL EMPTY CAPSULES MARKET REGIONAL OUTLOOK
7.1 Empty capsules market share, by region, 2015 & 2024
7.2 North America
7.2.1 North America empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.2.1.1 U.S. market estimates and forecasts
7.2.1.2 Canada market estimates and forecasts
7.2.2 North America empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.2.2.1 U.S. market estimates and forecasts
7.2.2.2 Canadamarket estimates and forecasts
7.2.3 North America empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.2.3.1 U.S. market estimates and forecasts
7.2.3.2 Canada market estimates and forecasts
7.3 Europe
7.3.1 Europe empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.3.1.1 UK market estimates and forecasts
7.3.1.2 Germany market estimates and forecasts
7.3.2 Europe empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.3.2.1 UK market estimates and forecasts
7.3.2.2 Germany market estimates and forecasts
7.3.3 Europe empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.3.3.1 UK market estimates and forecasts
7.3.3.2 Germany market estimates and forecasts
7.4 Asia Pacific
7.4.1 Asia Pacific empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.4.1.1 Japan market estimates and forecasts
7.4.1.2 China market estimates and forecasts
7.4.2 Asia Pacific empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.4.2.1 Japan market estimates and forecasts
7.4.2.2 China market estimates and forecasts
7.4.3 Asia Pacific empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.4.3.1 Japan market estimates and forecasts
7.4.3.2 China market estimates and forecasts
7.5 Latin America
7.5.1 Latin America empty capsules market estimates and forecasts, by products, 2013 - 2024 (USD Billion)
7.5.1.1 Brazil market estimates and forecasts
7.5.1.2 Mexico market estimates and forecasts
7.5.2 Latin America empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.5.2.1 Brazil market estimates and forecasts
7.5.2.2 Mexicomarket estimates and forecasts
7.5.3 Latin America empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.5.3.1 Brazil market estimates and forecasts
7.5.3.2 Mexicomarket estimates and forecasts
7.6 MEA
7.6.1 MEA empty capsules market estimates and forecasts, by product, 2013 - 2024 (USD Billion)
7.6.1.1 South Africa market estimates and forecasts
7.6.2 MEA empty capsules market estimates and forecasts, by therapeutic application, 2013 - 2024 (USD Billion)
7.6.2.1 South Africa market estimates and forecasts
7.6.3 MEA empty capsules market estimates and forecasts, by end user, 2013 - 2024 (USD Billion)
7.6.3.1 South Africa market estimates and forecasts
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Capsugel.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 ACG Worldwide.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 JC biological technologies.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Capscanada Corporation
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Medicaps Ltd
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Qualicaps
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Patheon Ltd
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Roxlor LLC.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Sunil Healthcare Ltd
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Nectar Lifesciences Ltd
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 Empty Capsules Market - Industry Summary & Critical Success Factors (CSFs)
Table 2 Empty capsules market, by product, 2013 - 2024 (USD billion)
Table 3 Empty capsules market, bytheapeutic application, 2013 - 2024 (USD billion)
Table 4 Empty capsules market, by end user, 2013 - 2024 (USD billion)
Table 5 Empty capsules market, by region, 2013 - 2024 (USD billion)
Table 6 Empty capsules market - Key market driver analysis
Table 7 Empty capsules market- Key market restraint analysis
Table 8 North America empty capsules market revenue, by product, 2013 - 2024 (USD billion)
Table 9 North America empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 10 North America empty capsules market revenue, by end user, 2013 - 2024 (USD billion)
Table 11 US empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 12 US empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 13 US empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 14 Canada empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 15 Canada empty capsules marketrevenue, bytherapeutic application, 2013 -2024 (USD Billion)
Table 16 Canada empty capsules marketrevenue, byend user, 2013 - 2024 (USD Billion)
Table 17 Europe empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 18 Europe empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 19 Europe empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 20 Germany empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 21 Germany empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 22 Germany empty capsules market revenue, by end user 2013 - 2024 (USD Billion)
Table 23 UK empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 24 UKempty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 25 UK empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 26 Asia Pacific empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 27 Asia Pacific empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 28 Asia Pacific empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 29 Japan empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 30 Japan empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 31 Japan empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 32 China empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 33 China empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 34 China empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 35 Latin America empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 36 Latin America empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 37 Latin America empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 38 Brazil empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 39 Brazil empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 40 Brazil empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 41 Mexico empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 42 Mexico empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 43 Mexico empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 44 MEA Empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 45 MEA empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 46 MEA empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 47 South Africa empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 48 South Africa empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 49 South Africa empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 1 Empty Capsules Market - Industry Summary & Critical Success Factors (CSFs)
Table 2 Empty capsules market, by product, 2013 - 2024 (USD billion)
Table 3 Empty capsules market, bytheapeutic application, 2013 - 2024 (USD billion)
Table 4 Empty capsules market, by end user, 2013 - 2024 (USD billion)
Table 5 Empty capsules market, by region, 2013 - 2024 (USD billion)
Table 6 Empty capsules market - Key market driver analysis
Table 7 Empty capsules market- Key market restraint analysis
Table 8 North America empty capsules market revenue, by product, 2013 - 2024 (USD billion)
Table 9 North America empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 10 North America empty capsules market revenue, by end user, 2013 - 2024 (USD billion)
Table 11 US empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 12 US empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 13 US empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 14 Canada empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 15 Canada empty capsules marketrevenue, bytherapeutic application, 2013 -2024 (USD Billion)
Table 16 Canada empty capsules marketrevenue, byend user, 2013 - 2024 (USD Billion)
Table 17 Europe empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 18 Europe empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 19 Europe empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 20 Germany empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 21 Germany empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 22 Germany empty capsules market revenue, by end user 2013 - 2024 (USD Billion)
Table 23 UK empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 24 UKempty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 25 UK empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 26 Asia Pacific empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 27 Asia Pacific empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 28 Asia Pacific empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 29 Japan empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 30 Japan empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 31 Japan empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 32 China empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 33 China empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 34 China empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 35 Latin America empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 36 Latin America empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 37 Latin America empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 38 Brazil empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 39 Brazil empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 40 Brazil empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 41 Mexico empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 42 Mexico empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 43 Mexico empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 44 MEA Empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 45 MEA empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 46 MEA empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
Table 47 South Africa empty capsules market revenue, by product, 2013 - 2024 (USD Billion)
Table 48 South Africa empty capsules market revenue, by therapeutic application, 2013 - 2024 (USD Billion)
Table 49 South Africa empty capsules market revenue, by end user, 2013 - 2024 (USD Billion)
